Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease.
Doisaki M, Katano Y, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Goto H, Fujita Y, Kadota Y, Kitaura Y, Bajotto G, Kazama S, Tamura T, Tamura N, Feng GG, Ishikawa N, Shimomura Y. Doisaki M, et al. Biochem Biophys Res Commun. 2010 Mar 5;393(2):303-7. doi: 10.1016/j.bbrc.2010.02.004. Epub 2010 Feb 6. Biochem Biophys Res Commun. 2010. PMID: 20138840
[A case of type 2 autoimmune pancreatitis associated with Crohn disease].
Ishikawa T, Haruta J, Yamaguchi T, Doisaki M, Yama T, Kamei K, Sawada T, Mizutani Y, Murakami Y, Hattori S. Ishikawa T, et al. Among authors: doisaki m. Nihon Shokakibyo Gakkai Zasshi. 2013 May;110(5):875-82. Nihon Shokakibyo Gakkai Zasshi. 2013. PMID: 23648545 Japanese.
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma.
Mori N, Tamaki N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Mori N, et al. Among authors: doisaki m. Invest New Drugs. 2024 Oct;42(5):559-565. doi: 10.1007/s10637-024-01470-y. Epub 2024 Aug 30. Invest New Drugs. 2024. PMID: 39212893
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma.
Tamaki N, Mori N, Takaki S, Tsuji K, Tada T, Nakamura S, Ochi H, Mashiba T, Doisaki M, Marusawa H, Kobashi H, Fujii H, Ogawa C, Nonogi M, Arai H, Uchida Y, Urawa N, Narita R, Akahane T, Kondo M, Yasui Y, Tsuchiya K, Izumi N, Kurosaki M. Tamaki N, et al. Among authors: doisaki m. Anticancer Res. 2024 Sep;44(9):3913-3918. doi: 10.21873/anticanres.17219. Anticancer Res. 2024. PMID: 39197893